Overview

The Effects of mETHotrexate Therapy on ST Segment Elevation MYocardial InfarctionS (TETHYS Trial)

Status:
Unknown status
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
Experimental studies suggest that anti-inflammatory and immunomodulatory drugs could reduce the inflammatory profile in acute ischemic disease and reduce the area of ischemia. Methotrexate is a drug that has shown promise in ischemic disease in animal studies.
Phase:
Phase 2
Details
Lead Sponsor:
Instituto de Cardiologia do Rio Grande do Sul
Collaborator:
Instituto de Cardiologia de Santa Catarina
Treatments:
Methotrexate
Riboflavin